Medigus (MDGS) is Expanding its Horizons Through Tech Investments and Creating Potential Near Term Catalysts in the Process
News out this morning. MDGS posts NET income for the first half 2021 $7.9M!
“Revenues for the six-month period ended June 30, 2021, reached a record high, and totaled $2,393,000, an increase of $2,320,000 compared to $73,000 in the six-month period ended June 30, 2020
Net income for the period reached a record of $7,927,000 compared to a net loss of $3,599,000 in the six-month period ended June 30, 2020
Shareholders’ equity totaled $53,904,000 as of June 30, 2021
Cash and cash equivalents totaled $29,642,000 as of June 30, 2021”
Full press release: https://finance.yahoo.com/news/medigus-ltd-announces-record-high-120000313.html
Holding more than 18 patents. Multiple catalysts lining up and an Aegis analyst price target represents a 400% increase from the current $1.48 PPS.
July 26th, 2021 – Medigus Board of Directors Decides to Promote a $2 Million Buyback Program
July 30th, 2021 – Medigus: Charging Robotics Successfully Completes a Proof of Concept for its Electric Vehicle Wireless Charging Robot
Initiating coverage on Medigus Ltd. (NASDAQ: MDGS), a technologies company that is focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce, and electric vehicle markets.
Current price $1.48/share
MDGS is a company with a lot of potential, and catalysts beginning to line up. MDGS has a diversified portfolio of tech investments, a modest share structure, an attractive entry share price and a strong financial position.
Considerations for MDGS:
Modest share structure with 23.8M shares outstanding and 23.6M in the public float. In June MDGS had $27M in cash and no debt beyond typical operating obligations.
The company shares seem priced at a value right now and are very close to their estimated book value of $1.45/share.
When I look at the company stock chart, I notice that the share price just crossed its 20 SMA and is very close to crossing its 50 SMA of $1.53. This condition can signal a significant swing coming. I also note that the company shares are trading significantly off their recent levels (and 64% off the 52-week high).
Products developed by Medigus:
ScoutCam develops and manufactures the smallest cameras produced in the world, which are down to 1mm diameter including illumination. ScoutCam devices have been used across the medical, aerospace, industrial, research, and defense industries.
The Medigus Ultrasonic Surgical Endostapler, or MUSE™ system, is a comprehensive endoscopic device that incorporates the latest technological advancements to deliver a more patient-friendly option for Transoral Fundoplication (TF), the procedure is intended to treat the leading cause of GERD (gastroesophageal reflux disease).
MDGS has more than 18 patents registered in their portfolio around the world.
MDGS has investments/activity in over 9 businesses of which 3 are currently public companies traded on the TASE and the OTC Market and involved in these sectors:
Medical
Polyrizon Ltd., a privately held company which Medigus owns 35.86% of its share capital, is evaluating the viral infection prophylaxis effect of its innovative product candidate against the Delta variant of the coronavirus (lineage B.1.617.2), in-vitro. This study follows recent pre-clinical studies showed strong potential against human coronavirus 229E and influenza virus infection.
Electric Vehicles
Revoltz, a joint venture between Medigus, through its wholly owned subsidiary, Charging Robotics Ltd., and Amir Zaid and Weijian Zhou, the founders of EMuze, is a privately held company that designs and develops electric micro-mobility vehicles. This month the company has begun the prototype manufacturing of its micro mobility vehicle.
E- Commerce
On August 31, 2021, MDGS, announced that its affiliate Gix Internet (36.74% on a fully diluted bases) (TASE: GIX), a global marketing technology (MarTech) solutions company for online performance-based-marketing, announced that Gix Internet’s subsidiary, Gix Media signed a definitive agreement for the purchase of 70% at Cortex Group.
Digital Marketing
Jeff’s Brands Ltd., and its subsidiaries Smart Repair Pro, Purex and Top Rank, leverage proprietary artificial intelligence (AI) and machine learning to analyze sales data and patterns within the multi-billion-dollar Amazon marketplace to identify stores, niches, and products with demonstrated growth potential to maximize sales within their Fulfillment by Amazon (FBA) shops.
Potential near-term catalysts and milestones:
Any development in Polyrizon toward FDA approval.
MUSE engaging in more licenses and sales agreements.
Commercializing new sectors for Scoutcam.
Launching of new products at Gix Group.
10/22/2020 Aegis Initiated Coverage Buy $6.00
I will have more info on the MDGS business model and potential soon.
About Medigus
Medigus Ltd. is a technologies company that is focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce, and electric vehicle markets. Medigus’ affiliations in the medical solutions arena consist of ownership in ScoutCam (OTCQB: SCTC), Inc, and Polyzion, LTD. The Company’s affiliates in digital commerce include Gix Internet Ltd. (TASE: GIX), Jeff’s Brands and Eventer Technologies, Ltd. In the electric vehicle market, Charging Robotics, Ltd. and Revolz are also part of the Company’s portfolio of technology solution providers.
The Traders News Group
Privacy Policy and Disclaimer
Your Consent
By using our site, you consent to our online privacy policy and disclaimer.
Do we disclose any information to outside parties?
We do not sell your information to anyone. Please see our cookie policy below.
https://tradersnewssource.com/cookie-policy-us/
What information do we collect?
We collect information from you when you subscribe to our newsletter or fill out a form on one of our social platforms. This includes your email address and or mobile phone number.
When registering on our site, as appropriate, you may be asked to enter your: e-mail address and or mobile number.
What do we use your information for?
When we collect your email or mobile number it is used for one purpose to send you the information you requested about small cap stocks. Please read our disclaimer carefully before viewing our emails.
Your information, whether public or private, will not be sold, exchanged, transferred, or given to any other company for any reason whatsoever, other than for the express purpose of delivering the information on small cap stocks that you requested.
We send periodic emails
The email address you provide may be used to send you information, the small cap stock reports you requested, respond to inquiries, and/or other requests or questions.
How do we protect your information?
We implement a variety of security measures to maintain the safety of your personal information when you enter, submit, your email address. We use secure third parties to send email and sms messages to you.
Because we value your privacy we have taken the necessary precautions to be in compliance with the California Online Privacy Protection Act.
Online Privacy Policy Policy
This online privacy policy applies to information collected through our website and social media platforms.
Contacting Us
If there are any questions regarding this privacy policy or disclaimer you may contact us using the information below.
Editor@TradersNewsSource.com
Traders News Source is a wholly owned subsidiary of Traders News Source LLC, herein referred to as TNS LLC.
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.
Please Note: TNS LLC and its employees are not a registered investment advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.